Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2004
12/01/2004CN1550550A Oncogene, recombinant protein derived therefrom, and uses thereof
12/01/2004CN1550235A Use of heparin-binding antagonists in the inhibition of bradykinin release
12/01/2004CN1177864C Novel human protein with expression difference in liver cancer tissue and its coding sequence
12/01/2004CN1177616C Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof
11/2004
11/30/2004US6825334 Interleukin-2 (il-2) for drugs/drug screening; genetic engineering; mitogen-activated protein kinases (map-k)
11/30/2004US6825332 Gene related to migraine in man
11/30/2004US6825326 Antibody which specifically binds to prostate stem cell antigen on surface of carcinoma cells and is internalized within carcinoma cells to which it binds
11/30/2004US6825325 Fusion proteins; membrane anchoring; genetic engineering; kits
11/30/2004US6825324 Antibodies to receptor protein tyrosine kinases
11/30/2004US6825322 Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor
11/30/2004US6825008 Expressed ligand—vascular intercellular signalling molecule
11/30/2004US6825007 Therapeutic and diagnostic methods and compositions based on Jagged/Notch proteins and nucleic acids
11/30/2004US6825006 Preparing an insect-resistant plant, genetic engineered insecticides, crystal protein from culturing the cells, encoding endotoxins having insecticidal activity
11/30/2004US6824997 For diagnosis of pneumonia/bronchitis/otitis media/sinusitis/meningitis using sample fluids (urine/blood/cerebrospinal fluid)
11/30/2004US6824993 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of prostate cancer
11/30/2004US6824989 Screening/detection of disease for diagnosis/research; genetic engineering; electrophoresis
11/30/2004US6824973 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferative disorders
11/30/2004US6824782 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
11/30/2004US6824781 Method of impairing movement of a CLA + memeory T-cell within or to the skin of a mammal by administering a CTACK antagonist
11/30/2004US6824780 Anti-tumor antibody compositions and methods of use
11/30/2004US6824779 Methods for inhibiting the interaction of B7-2 with its natural ligand
11/30/2004US6824778 Antibody for use in the prevention and treatment of viral diseases
11/30/2004US6824777 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
11/30/2004US6824775 88kDa tumorigenic growth factor and antagonists
11/30/2004US6824774 Comprises genetically engineered transcription factor for identifying elements associated neuronal differentiation/determination
11/30/2004US6824773 TWEAK receptor
11/30/2004CA2267072C Reconstituted human anti-hm1.24 antibody
11/30/2004CA2239099C Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
11/30/2004CA2144081C Protection against liver damage by hgf
11/30/2004CA2072350C Polypeptides involved in the expression of resistance to glycopeptides antibiotics
11/25/2004WO2004102199A2 Method for selecting and producing vaccine components and vaccines based thereon
11/25/2004WO2004102198A2 Selection of b cells with specificity of interest: method of preparation and use
11/25/2004WO2004101790A1 A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire
11/25/2004WO2004101777A1 A recombinant virus comprising an intact tumor-therapeutic antibody with human costant regions and the use thereof
11/25/2004WO2004101762A2 Detection and treatment of cancers of the colon
11/25/2004WO2004101756A2 Ovr110 antibody compositions and methods of use
11/25/2004WO2004101750A2 IL-23p40 SPECIFIC IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES
11/25/2004WO2004101740A2 Clotting factor-fc chimeric proteins to treat hemophilia
11/25/2004WO2004101739A2 Methods for chemically synthesizing immunoglobulin chimeric proteins
11/25/2004WO2004101738A2 Domain-exchanged binding molecules, methods of use and methods of production
11/25/2004WO2004101622A1 Human monoclonal antibody specific for lipopolysaccharides (lps) of serotype iats 06 of pseudomonas aeruginosa
11/25/2004WO2004101621A1 A SPECIFIC IMMUNOGLOBULIN (Ig) Y AGAINST SEVERVE ACUTE RTESPIRATORY SYNDROME (SARS) AND A PREPARING METHOD THEREOF AND COMBINATION PREPARATIOS CONTAINING IT
11/25/2004WO2004101612A2 Thioredoxin-peroxidase of c. albicans as a virulence-specific marker
11/25/2004WO2004101511A2 Anti-ip-10 antibodies and methods of using thereof for the treatment of inflamatory bowel diseases
11/25/2004WO2004100976A1 Klotho protein, anti-klotho protein antibody and use thereof
11/25/2004WO2004100951A1 Diabetic neuropathy diagnostic and therapeutic
11/25/2004WO2004100898A2 Therapeutic use of anti-cs1 antibodies
11/25/2004WO2004093662A3 Method for detecting prognosis of cancer
11/25/2004WO2004091511A3 Compositions and methods to diagnose and treat lung cancer
11/25/2004WO2004087216A3 Genetic immunization by means of multiple expression structures in order to produce monoclonal antibodies
11/25/2004WO2004087200A3 Vaccine and serum for protection of cystic fibrosis patients against pseudomonas aeruginosa
11/25/2004WO2004085479A3 Treatment of viral infections
11/25/2004WO2004085468A3 Human p53 splice variant displaying differential transcriptional activity
11/25/2004WO2004083387A3 Anti-ganglioside antibodies and methods of use
11/25/2004WO2004080420A3 A method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists
11/25/2004WO2004078123A3 Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use
11/25/2004WO2004071443A3 Methods and compositions for modulating stem cells
11/25/2004WO2004067567A3 Anti-dengue virus antibodies, compositions, methods and uses
11/25/2004WO2004065423A3 Recognition molecules for the treatment and detection of tumours
11/25/2004WO2004064724A3 Designed deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection
11/25/2004WO2004062462A3 Monclonal anitbodies to rna binding protein gw182
11/25/2004WO2004053063A3 Molecular determinants of myeloma bone disease and uses thereof
11/25/2004WO2004037209A3 METHODS TO PREVENT TUMOR RECURRENCE BY BLOCKADE OF TGF-β
11/25/2004WO2003050260A3 Streptavidin expressed gene fusions and methods of use thereof
11/25/2004US20040237125 Transforming hypermutable cells with vectors coding immunoglobulin gene sequences and generating antibodies which enhanced pharmacokinetic profiles; immunotherapy
11/25/2004US20040237124 Monoclonal antibody for use in prevention and treatment of osteoarthritic and surgical pain; immunotherapy
11/25/2004US20040236081 Immunoglobulin which binds interleukkin-1bconverting enzyme for use in diagnosis, treatment and prevention of autoimmune, neurodegenerative and cell proliferative disorders
11/25/2004US20040236080 Particularly having antibody-dependent cell-mediated cytotoxicity activity or complement-dependent cytotoxicity activity, used for treating cancer
11/25/2004US20040236079 IgG antibody, including a F(ab)'2 fragment, that induces platelet fragmentation and reacts with platelet epitope GPIIIa49-66 on platelet membranes
11/25/2004US20040236078 Binds p185HER2 and has a framework region (FR) substitution at a VH71, VH73, VH78, VH93, or VL66 FR position; has the low immunogenicity of huMAb4D5-8 upon repeated administration to treat breast cancer
11/25/2004US20040236077 Capable of specifically reacting with the N-terminal region of a partial peptide in a polypeptide with a specific amino acid sequence, used for diagnosis of pregnancy
11/25/2004US20040236075 Novel glass II cytokine receptors, and uses thereof
11/25/2004US20040236072 Immunogenic polynucleotides, polypeptides, and antibodies used for detecting, immunizing against, and reducing beta-hemolytic streptococcal infection
11/25/2004US20040235776 Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer
11/25/2004US20040235766 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication
11/25/2004US20040235740 Administered as antitumor, antimetastasis, anticarcinogenic and/or wound healing agent; tissue regeneration
11/25/2004US20040235729 Complementarity-determining region; monoclonal antibodies; antiidiotypic antibodies; autoantibodies; heavy chains; light chains; polypeptides; amino acid sequences; DNA; carriers; use for treatment of systemic lupus erythematosus in humans
11/25/2004US20040235722 Assay that makes use of the interaction of early pregnancy factor (EPF) or an EPF-related peptide with a human dorsal root receptor (hDRR) or hDRR related receptor; also useful to determine whether the test compound is an agonist or antagonist of hDRRs
11/25/2004US20040235173 Production of host cells containing multiple integrating vectors by serial transduction
11/25/2004US20040235118 Portions of soluble recombinant botulinum toxins
11/25/2004US20040235117 Fusion protein comprised of t umor necrosis factor, cartilage oligomeric and cartliage matrix protein domains for use in identifying modulator for treatment of infections, autoimmue, cell proliferative, neurodegenerative and inflammatory diseases
11/25/2004US20040235116 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
11/25/2004US20040235113 18 human secreted proteins
11/25/2004US20040235109 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/25/2004US20040235108 Immunoglobulin which competitively binds tetrameric form of the alpha-folate receptor for use in treatment and prevention of cell proliferfative disorders; immunotherapy
11/25/2004US20040235104 Nucleotide sequences coding similar expression of fibroblast growth factors genes (SEF) for use as tools in identifying modulators of cardiovascular, urogenital and cell proliferative disorders
11/25/2004US20040235102 Comprises adenosine triphosphate binding cassette membrane protein for use in identifying modulator which prevent transport of neurotoxic molecules; treating nervous system disorders
11/25/2004US20040235097 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
11/25/2004US20040235092 Comprises expression vectors coding heterologous protein for use as tools in diagnosis and treatment of cell proliferative, nervous system, inflammatory and autoimmune diseases
11/25/2004US20040235083 Screening method
11/25/2004US20040235074 Methods for the treatment or prevention of immune disorders using anti-CD40 antibodies
11/25/2004US20040235072 Compositions and methods for the therapy and diagnosis of lung cancer
11/25/2004US20040235066 Using immunoglobulin specific to cancer testis-antigens for use in diagnosis and treatment of cell proliferative diseaes; immunotherapy
11/25/2004US20040235065 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
11/25/2004US20040235058 ULBP antibodies
11/25/2004US20040235047 Therapeutic agent comprising cytokine inhibitory activity for use in treatment of respiratory system disorders; viricides; antisense agents; enzyme inhibitors; immunotherapy; RNA interference; recombinant cytokine receptors
11/25/2004US20040235038 Using single-stranded conformational polymorphisms to identify mutation which lead to cardiovascular disorders; identifying modulator for treatment of cardiac disorders
11/25/2004US20040235020 Methods for monitoring drug activities in vivo
11/25/2004US20040235018 Nucleotide sequences coding zinc finger protein for use in identifying modulators of cell proliferation disorders; antitumor agents
11/25/2004US20040235011 Production of multimeric proteins